BAX and nasopharyngeal carcinoma: This finding along with the fact that the BAX inhibitor TMBIM6 mediates resistance to apoptosis in human NPC cells [60] directly imply that dysregulation of BAX is implicated in nasopharyngeal carcinogenesis.